Full text is available at the source.
Abstract
Semaglutide promotes weight loss and may have anti-inflammatory effects.
- Obesity is linked to chronic inflammation and increased risk of heart and metabolic diseases.
- Semaglutide is approved for managing weight in individuals with obesity.
- The medication works by reducing appetite and slowing the emptying of the stomach.
- There is a need for updated evaluation of semaglutide's efficacy and safety in individuals without diabetes who are overweight or obese.
Simplified